Boston Scientific (BSX) Receivables - Net (2009 - 2026)

Boston Scientific's Receivables - Net history runs 18 years deep, the most recent figure standing at $3.2 billion for Q1 2026.

• In Q1 2026, Receivables - Net rose 12.4% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 12.4% YoY), while the FY2025 annual figure was $3.1 billion, up 14.66% from the prior year.
• Receivables - Net came in at $3.2 billion for Q1 2026 at Boston Scientific, up from $3.1 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $3.2 billion in Q1 2026 to a low of $1.9 billion in Q1 2022.
• A 5-year average of $2.4 billion and a median of $2.4 billion in 2024 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net grew 4.45% in 2022 and increased 24.23% in 2024, its largest moves.
• Boston Scientific's Receivables - Net stood at $2.0 billion in 2022, then increased by 18.68% to $2.3 billion in 2023, then climbed by 14.07% to $2.7 billion in 2024, then grew by 14.66% to $3.1 billion in 2025, then gained by 3.14% to $3.2 billion in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $3.2 billion, $3.1 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison